Attorney Guo specializes in corporate and commercial legal practice, with expertise in equity structure design, investment and financing, M&A, debt restructuring, and debt disposal. She also has experience in civil and commercial dispute resolution, enabling her to provide one-stop legal services to corporate clients covering both non-litigation and litigation matters. She has served multiple state-owned enterprises, listed companies, and private equity funds, possessing dual capabilities in non-litigation project management and litigation dispute resolution.

Attorney Guo has accumulated extensive practical experience in major investment and M&A transactions, having led multiple industry-influential deals. She has represented CR Sanjiu (000999) in acquiring the controlling interest of Tasly Pharmaceutical (600535) and the related major asset restructuring project of CR Sanjiu, as well as CR Sanjiu's acquisition of the controlling interest of Yunnan Baiyao Group (600422) and the related major asset restructuring project (serving as signing attorney). Additionally, she has represented CR Sanjiu in a pharmaceutical cooperation project with STADA Arzneimittel, represented CR Sanjiu in investing in Runsheng Pharmaceutical, and participated in competitive negotiations for the group's disposal of certain domestic assets.